Filtered By:
Source: MedPage Today Cardiovascular
Drug: Activase

This page shows you your search results in order of date.

Order by Relevance | Date

Total 4 results found since Jan 2013.

Dual Antiplatelet Therapy Proves Mettle in Minor Stroke
(MedPage Today) -- DALLAS -- Dual antiplatelet therapy (DAPT) proved non-inferior to IV alteplase in Chinese patients with minor non-disabling stroke, a researcher reported. In the ARAMIS trial of patients with acute minor stroke who presented...
Source: MedPage Today Cardiovascular - February 13, 2023 Category: Cardiology Source Type: news

Tenecteplase on Par With Alteplase, Randomized Trial Affirms
(MedPage Today) -- DALLAS -- Tenecteplase (TNKase) did as good a job at ischemic stroke thrombolysis as did alteplase (Activase) for patients presenting within 4.5 hours of symptom onset in the randomized TRACE-2 trial from China. The proportion...
Source: MedPage Today Cardiovascular - February 9, 2023 Category: Cardiology Source Type: news

Tenecteplase Superior to Alteplase for Stroke Lysis
(MedPage Today) -- But likelihood of gaining an official stroke indication appears remote
Source: MedPage Today Cardiovascular - January 25, 2018 Category: Cardiology Source Type: news

More Brain Bleeds With Stroke Drug in 'Real World?
BOSTON (MedPage Today) -- In a real-world practice setting, the use of tissue plasminogen activator (tPA, Alteplase) results in a higher rate of intracerebral hemorrhage than was seen in well-controlled clinical trials, researchers said here.
Source: MedPage Today Cardiovascular - May 28, 2014 Category: Cardiology Source Type: news